Non Substitutive Strategies to Improve Haemophilia Care in Developing Countries. Experience in Ivory Coast.

Status

Completed

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT03054662

Enrollment

142

Registered

2017-02-15

Start date

2017-01-16

Completion date

2019-09-17

Last updated

2019-09-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Developing Countries, Haemophilia

Keywords

Haemophilia

Brief summary

This study aims to make an inventory of the condition and care of patients with haemophilia and carriers for haemophilia in Ivory Coast and to promote the use non substitutive strategies that are not costly and available in Ivory Coast, to improve the management of haemophilia in this country. The purpose of this project is to evaluate the extent to which the active promotion of these various measures will improve the care of patients with haemophilia and carriers in Ivory Coast.

Detailed description

1. Establish a baseline of the condition of haemophilia in Ivory Coast (number of patients, demographics, reassessment of diagnosis, joint status...).(year 1) 2. Develop tools to assess the intervention (eg transcultural validation of QoL questionnaires, develop booklets to record bleedings...). (year 1) 3. Intervention phase that will focus on education of patients and their family, education of caregivers, training of the laboratory to the diagnosis of haemophilia and promotion of non substitutive strategies to improve haemophilia care in Ivory Coast (DDAVP, antifibrinolytics, physiotherapy, dental care,...). 4. Follow-up phase during 2 years. 5. Outcome analysis

Interventions

OTHEREducation

Education of patients and caregivers about haemophilia and carriers of haemophilia.

DIAGNOSTIC_TESTImprove biological diagnosis and follow-up of haemophilia

train the laboratory to the diagnosis ans follow-up un haemophilia

DRUGImplement haemostatic non substitutive care of haemophilia

Implement the use of DDAVP and antifibrinolytics in patients with haemophilia and symptomatic carriers

OTHERImplement non haemostatic care of haemophilia

Implement regular physiotherapy, develop dental care, promote the regular use of pain killers

Study design

Allocation

NON_RANDOMIZED

Intervention model

SINGLE_GROUP

Primary purpose

OTHER

Masking

NONE

Intervention model description

monocentric prospective study with longitudinal data collection of a single group

Eligibility

Sex/Gender

ALL

Age

12 Years to No maximum

Healthy volunteers

Inclusion criteria

* Males with severe and moderate haemophilia A and B in Ivory Coast (any age). * Females over 12 years who are carriers for severe and moderate haemophilia A and B in Ivory Coast. *

Exclusion criteria

subjects not willing to participate.

Design outcomes

Primary

Measure	Time frame	Description
Improve haemophilia care in Ivory Coast	2 years after intervention	Compare QoL questionnaires before and after the intervention phase
Improve haemophilia diagnosis of haemophilia in Ivory Coast	3 years	Compare the number of patients with haemophilia between the beginning and the end of the study
Improve knowledge about haemophilia in Ivory Coast	2 years after intervention	Compare the knowledge queestionnaires about haemophilia before and after the intervention phase

Countries

Côte d’Ivoire

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026